Sun Pharmaceutical

Sun Pharma announces pre-clinical data on GL0034, an experimental NCE to treat Type 2 diabetes and obesity

Read more

Sun Pharma and Rockwell enter into licensing agreement for Triferic in India

Read more

Sun Pharma reports Q1FY20 results

Read more

Sun Pharma Announces Regulatory Filing of Tildrakizumab in Japan

Read more

US FDA finds “significant violations” at India’s Strides plant

Read more

Strides Shasun gets CCI nod to buy Sun Pharma’s two divisions

Read more

Sun Pharma divests US manufacturing unit

Read more

Sun Pharma seeks shareholders’ approval on Rs 50,000 cr provision

Read more